Medical University Of South Carolina
Bicycle-related injuries decreased in last decade despite increased public utilization
Despite a 62% increase in public bicycle utilization from 2000 to 2014, according to the 2014 American Community Survey, recently published results showed a “significant downtrend” in bicycle-related injuries from 2012 to 2021.
In FH, Lp(a) levels comparable to LDL in risk for premature poor outcomes
Lipoprotein(a) levels of 67 mg/dL or more may be indicative of similar risk for premature MI as LDL of 180 mg/dL or more in patients with familial hypercholesterolemia, researchers reported.
No elevated mortality risk with heart transplants donated after circulatory death
Patients with heart transplants involving donation after circulatory death have no detectable difference in survival compared with those with hearts donated after brain death, according to a study published in Circulation: Heart Failure.
Nerve procedures added to amputation linked with lower costs, shorter hospital stay
BOSTON — Health care system expenditures and patient satisfaction can be improved with the addition of nerve interventions to upper extremity amputations, according to a presenter.
Diabetes clinical trials located in few socially disadvantaged counties in US
Measures of social determinants of health are substantially different in U.S. counties with diabetes clinical trial sites compared with counties with no trial sites, according to a research letter published in Diabetes Care.
Tranexamic acid may reduce complications in ankle, hindfoot surgery
CHICAGO — Tranexamic acid in total ankle arthroplasty and hindfoot fusion may reduce the number of superficial infections, provide shorter time to union and decrease rates of delayed wound healing, according to results presented here.
After AF ablation, dronedarone may be safer, more effective than sotalol
After atrial fibrillation ablation, dronedarone was associated with lower risk for recurrent hospitalizations and repeat AF ablations compared with sotalol, researchers reported.
Trial of acoramidis for transthyretin amyloid cardiomyopathy misses primary endpoint
In the 12-month topline results of the ATTRibute-CM trial, acoramidis, a treatment for symptomatic transthyretin amyloid cardiomyopathy, did not meet its primary endpoint, BridgeBio Pharma announced.
Patients with low stroke score may reach functional independence
Methylphenidate may reduce apathy in AD
Methylphenidate safely and effectively treated apathy in Alzheimer’s disease, according to results of a randomized placebo-controlled clinical trial published in JAMA Neurology.